Drug Delivery News and Research

RSS
Drug delivery is a term that refers to the delivery of a pharmaceutical compound into the body. Most common methods of delivery include the preferred non-invasive oral (through the mouth), nasal, pneumonial (inhalation), and rectal routes. Much research is now focussing on nanotechnology as a drug delivery method.

Further Reading

Positive results from azide drug-loaded Emulsiphan preclinical toxicity study

Positive results from azide drug-loaded Emulsiphan preclinical toxicity study

14 Mar 2011
SCLR announces FDA's issue of deficiency letter for pseudoephedrine ANDA

SCLR announces FDA's issue of deficiency letter for pseudoephedrine ANDA

14 Mar 2011
Halozyme Therapeutics 2010 net loss decreases to $53.2 million

Halozyme Therapeutics 2010 net loss decreases to $53.2 million

11 Mar 2011
BDSI prices $15 million private placement

BDSI prices $15 million private placement

11 Mar 2011
Columbia fourth quarter total net revenues increase 74% to $14.9 million

Columbia fourth quarter total net revenues increase 74% to $14.9 million

10 Mar 2011
Positive results from Creabilis CT327 Phase IIa study in patients with psoriasis vulgaris

Positive results from Creabilis CT327 Phase IIa study in patients with psoriasis vulgaris

10 Mar 2011
FDA accepts Tris' Extended Release Carbinoxamine Oral Suspension NDA for allergies in kids

FDA accepts Tris' Extended Release Carbinoxamine Oral Suspension NDA for allergies in kids

10 Mar 2011
TARIS commences LiRIS Phase 1B clinical study in interstitial cystitis

TARIS commences LiRIS Phase 1B clinical study in interstitial cystitis

10 Mar 2011
EDT receives European approval for XEPLION injection to treat schizophrenia

EDT receives European approval for XEPLION injection to treat schizophrenia

9 Mar 2011
U.S. FDA approves Hospira's docetaxel to treat variety of cancers

U.S. FDA approves Hospira's docetaxel to treat variety of cancers

9 Mar 2011
Single-wall carbon nanotubes targeted and killed cancer cells without harming the healthy cells

Single-wall carbon nanotubes targeted and killed cancer cells without harming the healthy cells

8 Mar 2011
Alliqua completes transdermal pain patch initial in vitro study for treatment of PHN

Alliqua completes transdermal pain patch initial in vitro study for treatment of PHN

8 Mar 2011
Aerie Pharmaceuticals closes $30 million Series B financing

Aerie Pharmaceuticals closes $30 million Series B financing

7 Mar 2011
Oxford Instruments patents to be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction

Oxford Instruments patents to be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction

5 Mar 2011
Depomed completes patient enrollment in Breeze 3 Serada Phase 3 trial to treat menopausal hot flashes

Depomed completes patient enrollment in Breeze 3 Serada Phase 3 trial to treat menopausal hot flashes

3 Mar 2011
International Surf Resorts to acquire BioZone Laboratories

International Surf Resorts to acquire BioZone Laboratories

2 Mar 2011
Pluristem's PLX cells exhibit potential to treat accidental and intentionally induced muscle injuries

Pluristem's PLX cells exhibit potential to treat accidental and intentionally induced muscle injuries

2 Mar 2011
EPO to grant patent for Apricus MycoVa product to treat nail fungus

EPO to grant patent for Apricus MycoVa product to treat nail fungus

2 Mar 2011
Nanotechnology holds promise for developing surgical measures

Nanotechnology holds promise for developing surgical measures

2 Mar 2011
FDA clears Valeritas' V-Go Disposable Insulin Delivery Device for use with NovoLog

FDA clears Valeritas' V-Go Disposable Insulin Delivery Device for use with NovoLog

1 Mar 2011

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback